What one share of Metagenomi Therapeutics holds
We are an in vivo genome editing company capitalizing on our proprietary technologies to create curative genetic medicines for patients. We were founded on the science of metagenomics, the study of genetic materials recovered from the natural environment, to discover and develop a suite of novel gene editing tools potentially capable of correcting any type of genetic mutation found anywhere in the human genome.
Metagenomi Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$2.49 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$2.29 |
| Cash and investments | $1.03 |
| Book value | $2.98 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $13.15 | −$20.05 | $2.88 | −$29.73 | — | −$39.82 |
| 2024 | $1.58 | −$2.36 | $0.09 | −$3.40 | — | $6.28 |
| 2025 | $0.68 | −$2.36 | $0.02 | −$2.40 | — | $4.22 |
Common questions about Metagenomi Therapeutics
How much does one share of Metagenomi Therapeutics earn?
Over the last 12 months, Metagenomi Therapeutics lost $2.49 for each share.
Does Metagenomi Therapeutics pay a dividend?
Metagenomi Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Metagenomi Therapeutics’s book value per share?
Metagenomi Therapeutics’s book value is $2.98 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Metagenomi Therapeutics have?
Each share of Metagenomi Therapeutics has $1.03 of cash and investments, as of June 30, 2026.
What is Metagenomi Therapeutics’s free cash flow per share?
−$2.29 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.